Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Coronavirus
Health
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Trending
In a doctor’s suspicion after a miscarriage, a glimpse…
In a doctor’s suspicion after a miscarriage, a glimpse of expanding medical mistrust
Monkeypox - purple
The next epidemic may be here. The U.S. isn’t…
The next epidemic may be here. The U.S. isn’t ready for it
Comparing the Pfizer and Moderna Covid vaccines for young…
Comparing the Pfizer and Moderna Covid vaccines for young children
Recommended
Pharmalot Coming/Going STILL
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: Senate Dems vet a tweaked version of drug-pricing…
Pharmalittle: Senate Dems vet a tweaked version of drug-pricing bill; biotechs double down on developing birth…
Adam's take main illustration
Not-so-happy midyear! Biotech CEOS, best and worst, and a…
Not-so-happy midyear! Biotech CEOS, best and worst, and a hopeful sign of a turnaround

Recommended Stories

Fish oil capsule
Biotech

New analysis of Amarin’s Vascepa resurrects big questions about effectiveness

By Matthew Herper

Hospitals

A rich Republican businessman is an unlikely champion for lower hospital prices — but he’s winning the fight

By Rachel Cohrs

Cue Health overgrowth illustration
A STAT Investigation

Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

By Katie Palmer